MP0250
a recombinant polypeptide consisting of anti-vascular endothelial growth factor-A (VEGF-A), one anti-hepatocyte growth factor (HGF), and two anti-human serum albumin (HSA) DARPin domains
Networked: 4
relevant articles (0 outcomes,
3 trials/studies)
Bio-Agent Context: Research Results
Experts
1. | Fiedler, Ulrike:
4 articles
(10/2021 - 11/2017)
|
2. | Stumpp, Michael T:
3 articles
(10/2021 - 11/2017)
|
3. | Dawson, Keith M:
2 articles
(10/2021 - 11/2017)
|
4. | Harstrick, Andreas:
2 articles
(10/2021 - 03/2018)
|
5. | Zitt, Christof:
2 articles
(10/2021 - 11/2017)
|
6. | Bakker, Talitha R:
2 articles
(11/2017 - 11/2017)
|
7. | Cornelius, Andreas:
2 articles
(11/2017 - 11/2017)
|
8. | Dolado, Ignacio:
2 articles
(11/2017 - 11/2017)
|
9. | Ekawardhani, Savira:
2 articles
(11/2017 - 11/2017)
|
10. | Azaro, Analía:
1 article
(10/2021)
|
Related Diseases
Related Drugs and Biologics